Trial
NCT06929260
A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Advanced Solid Tumours
Intervention
Ceralasertib
Why stopped
The study terminated because the clinical development programme for Ceralasertib has been discontinued.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-22